Pretransplant conditioning with fludarabine and IV busulfan, reduced toxicity and increased safety without compromising antitumor efficacy and overall treatment effect?

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Bone marrow transplantation (Basingstoke) 2016-07, Vol.51 (7), p.919-920
Hauptverfasser:	Andersson, B S, Valdez, B C
Format:	Artikel
Sprache:	eng
Schlagworte:	631/67/1059 692/308/2779 Anticancer properties Antitumor activity Bone marrow Busulfan Cell Biology commentary Dosage and administration Fludarabine Graft vs Host Disease Hematology Hematopoietic Stem Cell Transplantation Humans Internal Medicine Medicine Medicine & Public Health Methods Patient outcomes Preoperative care Public Health Stem cell transplantation Stem Cells Toxicity Transplantation Conditioning Transplantation, Homologous Vidarabine - analogs & derivatives
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!